Page 106 - MBCA_FULL REPORT_FINAL_FOR_WEB

References

1. Society, A.C., American Cancer Society. Breast Cancer Facts & Figures 2013-2014. Atlanta: American Cancer
Society, Inc. . 2013.
2. Pal, S.K., Lack of survival benefit in metastatic breast cancer with newer chemotherapy agents: The City of
Hope cancer experience. Journal of Clinical Oncology, 2008. 26(Supplement).
3. Mayer, M. and S.E. Grober, Silent Voices: Women with Advanced (Metastatic) Breast Cancer Share Their
Needs and Preferences for Information, Support, and Practical Resources. 2006: Living Beyond Breast Cancer
website.

4. Kroenke, K., et al., The association of depression and pain with health-related quality of life, disability, and
health care use in cancer patients. J Pain Symptom Manage, 2010. 40(3): p. 327-41.
5. Hanahan, D. and R.A. Weinberg, Hallmarks of cancer: the next generation. Cell, 2011. 144(5): p. 646-74.
6. Steeg, P.S., Tumor metastasis: mechanistic insights and clinical challenges. Nat Med, 2006. 12(8): p. 895-
904.
7. Fidler, I.J., The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer,
2003. 3(6): p. 453-8.
8. Institute, N.C., National Cancer Institute Fact Sheet: Targeted Cancer Therapies. 2014.

9. ICRP. International Cancer Research Partnership. Available from: http://www.icrpartnership.org/.
10. ICRP, Cancer Research Funding from an International Perspective, L. Davies, Editor. 2012, International
Cancer Research Partnership.
11. O’Toole, L., P. Nurse, and G. Radda, An analysis of cancer research funding in the UK. Nat Rev Cancer, 2003.
3(2): p. 139-43.
12. Nurse, P., et al., Cancer research: joint planning for the future. Ann Oncol, 2003. 14(11): p. 1593-4.
13. Myers, E.R., et al., Similarities and differences in philanthropic and federal support for medical research in
the United States: an analysis of funding by nonprofits in 2006-2008. Acad Med, 2012. 87(11): p. 1574-81.

14. TBCRC. Translational Breast Cancer Research Consortium. Available from: http://pub.emmes.com/study/
bcrc/.
15. Eccles, S.A., et al., Critical research gaps and translational priorities for the successful prevention and
treatment of breast cancer. Breast Cancer Res, 2013. 15(5): p. R92.

16. Criscitiello, C., et al., Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and
future perspectives. Breast Cancer Res, 2014. 16(2): p. 205.
17. Sleeman, J. and P.S. Steeg, Cancer metastasis as a therapeutic target. Eur J Cancer, 2010. 46(7): p. 1177-80.
18. Steeg, P.S., Perspective: The right trials. Nature, 2012. 485(7400): p. S58-9.

19. Hanahan, D., Rethinking the war on cancer. Lancet, 2014. 383(9916): p. 558-63.
20. Sledge, G.W., et al., A dickens tale of the treatment of advanced breast cancer: the past, the present, and
the future. Am Soc Clin Oncol Educ Book, 2012: p. 28-38.
21. Floor, S.L., et al., Hallmarks of cancer: of all cancer cells, all the time? Trends Mol Med, 2012. 18(9): p. 509-15.

22. Hu, J., et al., Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell,
2012. 148(4): p. 651-63.
106